Breaking News: InMed Pharmaceuticals Inc. (OTCQX: IMLFF TSX: IN)

Breaking News: InMed Pharmaceuticals Inc. (OTCQX: IMLFF TSX: IN) – RICH TV LIVE – October 3, 2018 – a cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, is pleased to announce entering into a research agreement with the National Research Council of Canada (NRC) in Montreal, Canada, for biofermentation development and scale-up processes for cannabinoid biosynthesis in E.coli.

All right guys this is rich here on behalf of rich tv live we’re 13 days 15 hours 43 minutes and 32 seconds away from history in canada cannabis will be legalized in canada and you can find out all the news all the information at wwe tv live.com hover over stocks all the tools are there find out all the breaking news about cannabis stocks and global news right there

Under news everything about kryptos everything you need to know about sports and if you want to follow us and join our secret amino social media platform where we have a free community for investors and people to just chat just join right there absolutely free just download amino on your phone or on your computer and join the discussion we also have a free group

Chat on slack and discord and you can follow us on all social media so what is the news today we’re so far we’re in a green day today in the cannabis sector so lots of green all the way around so it’s a good day so far and in med pharmaceuticals as a company i own i love it i n in canada i am lff in america they’ve got some breaking news it just dropped this morning

See also  10 Things Everyone Should Know How To Cook For Themselves | The Financial Diet

In met pharmaceutical sign agreement with the national research council of canada for cannabinoid bio fermentation process development and scale-up this is a company that i love it’s a long-term opportunity and i believe it will explode okay in met pharmaceuticals inc a cannabinoid based biopharmaceutical company that leverages is proprietary platform technologies

To develop novel therapeutics for the treatment of diseases with high unmet medical needs is pleased to announce entering into a research agreement with the national research council of canada otherwise known as the nrc in montreal canada for bio fermentation development and scale-up processes for cannabinoid biosynthesis in e.coli you can see the news at in meds

Website in meds vice-president preclinical research and element eric hisui phd commented the nrc has significant bio fermentation expertise and extensive facilities to support in meds scale-up activities the nrc will help us define specific processes parameters to improve fermentation skill and product yield needed for in med to maximize the commercial potential

Of our proprietary ecoli based cannabinoid biosynthesis system this work is the natural progression of several years history in designing cannabinoid specific vectors at the university of british columbia and the next step in researching our goal of establishing a leadership position in the field of cannabinoid bio synthesis this is huge about in med in med is a

Preclinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems in meds proprietary bioinformatics database drug disease targeting tool cannabinoid biosynthesis technology and drug development pipeline are

See also  Elon Musk settlement with SEC costs him Tesla (NASDAQ: TSLA) chairmanship and 0 million fine

The fundamental values drivers of the company for more information visit in med pharma comm let’s just go check that wwe n med pharma take a look at their website real quick bam unlocking the potential of cannabinoid medicine you know your boy rich loves cannabinoids and i love in med pharmaceuticals i’ve made a substantial investment in this company i believe in

Them long term this is some big news i’d like to know what you guys think about this news now remember rich tv live is strictly for education entertainment purposes always do your due diligence always do your research before you invest in anything that we talk about here on rich tv live you can see it is up 118 percent since october of last year in less than a year

22 percent in the last three months 10 percent in the last month has not exploded yet people i see huge upside for this company i’d like to know what you guys think if you like this video smash the like button comment down below share this video everywhere remember if i win and you win we all win this is a company on the toronto stock exchange it’s really really

Cheap still and i think it had the chance to be a big winner what do you think we are 13 days 15 hours 38 minutes and 45 seconds away from history it met pharmaceuticals making waves breaking news if you’re not winning you’re not watching your boy rich no mo peace

Transcribed from video
Breaking News: InMed Pharmaceuticals Inc. (OTCQX: IMLFF TSX: IN) By RICH TV LIVE

See also  The 4 Skincare Routine That Changed My Life At 26 | Making it Work
Scroll to top